{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-134349","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2024-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.796377+00:00","generated_at":"2026-05-29T05:45:36.130589+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Disc Medicine reviews ASH 2024 clinical data for bitopertin, DISC-0974, DISC-3405","bullets":["Company held conference call on Dec 8 to review data presented at ASH Annual Meeting.","Operational plans discussed alongside clinical updates for three pipeline programs.","Specific data results or guidance not provided in the 8-K filing; only presentation referenced.","Programs include bitopertin, DISC-0974, and DISC-3405."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-134349","json":"https://secwatch.observer/filing/0000950170-24-134349.json","markdown":"https://secwatch.observer/filing/0000950170-24-134349.md","text":"https://secwatch.observer/filing/0000950170-24-134349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024134349/0000950170-24-134349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024134349/iron-20241208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:45:36.130589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}